Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
TRIM21 induces selective autophagy of viruses and bacteria.
Journal: Molecular cell
Published: April 30, 2025
Aggregate-selective removal of pathological tau by clustering-activated degraders.
Journal: Science (New York, N.Y.)
Published: August 29, 2024
Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function.
Journal: Cell
Published: February 16, 2024
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models.
Journal: Nature communications
Published: January 23, 2024
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery.
Journal: PNAS nexus
Published: September 21, 2023
The type-I interferon response potentiates seeded tau aggregation and exacerbates tau pathology.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: May 04, 2023
Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models.
Journal: Science (New York, N.Y.)
Published: March 30, 2023
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2.
Journal: Nature communications
Published: November 08, 2022
IP6-stabilised HIV capsids evade cGAS/STING-mediated host immune sensing.
Journal: EMBO reports
Published: October 11, 2022
Cholesterol determines the cytosolic entry and seeded aggregation of tau.
Journal: Cell reports
Published: September 24, 2021
Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice.
Journal: FEBS letters
Published: June 10, 2021
A functional assay for serum detection of antibodies against SARS-CoV-2 nucleoprotein.
Journal: The EMBO journal
Published: April 27, 2021
Last Updated: 09/26/2026